Germany
Japan
United Kingdom
China
USD 509.00
5 Days
Primary Antibodies
View as table Download
USD 509.00
In Stock
USD 509.00
2 Weeks
USD 509.00
2 Weeks
USD 509.00
5 Days
USD 509.00
2 Weeks
USD 509.00
2 Weeks
USD 509.00
5 Days
USD 509.00
2 Weeks
Complement C3 (C3) goat polyclonal antibody, HRP
| Applications | ELISA, ID, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | HRP |
| Immunogen | C3c is isolated and purified from pooled normal human serum by precipitation techniques, followed by chromatographical methods. Freund’s complete adjuvant is used in the first step of the immunization. |
Lactoferrin (LTF) goat polyclonal antibody, HRP
| Applications | ELISA, ID, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | HRP |
| Immunogen | The immunogen has been isolated from human milk. Freund’s complete adjuvant is used in the first step of the immunization procedure. |
Lactoferrin (LTF) goat polyclonal antibody, HRP
| Applications | ELISA, ID, IF, IHC, IP, WB |
| Reactivities | Monkey |
| Conjugation | HRP |
| Immunogen | Exocrine organs produce various secretions, each with its characteristic function. Proteins found in secretions may be divided into two groups: those specific for the particular secretion, and plasma proteins independent of the type of exocrine cells. Lactoferrin belongs to the first group. It is an iron containing protein with a molecular weight of 75,000 and it is antigenically different from transferrin. Lactoferrin has a slight anti-microbial action. Originally identified in milk, its presence has also been demonstrated in other secretions as saliva, semen and tears. The immunogen has been isolated from rhesus monkey milk. Freund’s complete adjuvant is used in the first step of the immunization procedure. |
Complement C3 (C3) chicken polyclonal antibody, HRP
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | HRP |
| Immunogen | Purified Human Complement Component 3a (C3a) peptide. |
Lactoferrin (LTF) mouse monoclonal antibody, clone NI 25, HRP
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | HRP |
Active filters
Category
-
Antibodies
- Primary Antibodies
Conjugates
- HRP
Assay Types
- Direct
Families
- Druggable Genome
Filter by
Target Symbol
Reactivities
Applications
Antibody Hosts
Clonalities
Knockout (KO) Validation
Pathways
- Cell adhesion molecules (CAMs) (12)
- Pathways in cancer (8)
- Bladder cancer (7)
- Cytokine-cytokine receptor interaction (7)
- Systemic lupus erythematosus (7)
- Chemokine signaling pathway (6)
- MAPK signaling pathway (6)
- T cell receptor signaling pathway (6)
- Toll-like receptor signaling pathway (6)
- Allograft rejection (5)
- Endometrial cancer (5)
- ErbB signaling pathway (5)
- Graft-versus-host disease (5)
- Natural killer cell mediated cytotoxicity (5)
- Prostate cancer (5)
- Type I diabetes mellitus (5)
- Acute myeloid leukemia (4)
- Autoimmune thyroid disease (4)
- Chronic myeloid leukemia (4)
- Colorectal cancer (4)
- Focal adhesion (4)
- Glioma (4)
- Melanoma (4)
- NOD-like receptor signaling pathway (4)
- Non-small cell lung cancer (4)
- Pancreatic cancer (4)
- Regulation of actin cytoskeleton (4)
- Thyroid cancer (4)
- Viral myocarditis (4)
- Antigen processing and presentation (3)
- Insulin signaling pathway (3)
- Jak-STAT signaling pathway (3)
- Long-term depression (3)
- Long-term potentiation (3)
- Metabolic pathways (3)
- Neurotrophin signaling pathway (3)
- Progesterone-mediated oocyte maturation (3)
- Renal cell carcinoma (3)
- Vascular smooth muscle contraction (3)
- mTOR signaling pathway (3)
- Complement and coagulation cascades (2)
- Fc epsilon RI signaling pathway (2)
- Hematopoietic cell lineage (2)
- RIG-I-like receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Adipocytokine signaling pathway (1)
- Alzheimer's disease (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Apoptosis (1)
- Asthma (1)
- Cell cycle (1)
- Dilated cardiomyopathy (1)
- Endocytosis (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Gap junction (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Leukocyte transendothelial migration (1)
- Neuroactive ligand-receptor interaction (1)
- Small cell lung cancer (1)
- Type II diabetes mellitus (1)
- Wnt signaling pathway (1)